139 related articles for article (PubMed ID: 1911424)
21. Characterization of an antiestrogen-binding protein in high salt extracts of human breast cancer tissue.
Kon OL
J Steroid Biochem; 1985 Feb; 22(2):177-86. PubMed ID: 3982029
[TBL] [Abstract][Full Text] [Related]
22. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
Ruh TS; Baudendistel LJ
Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
[TBL] [Abstract][Full Text] [Related]
23. Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.
Mehta RR; DasGupta TK
Breast Cancer Res Treat; 1987; 9(1):61-7. PubMed ID: 3593991
[TBL] [Abstract][Full Text] [Related]
24. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
[TBL] [Abstract][Full Text] [Related]
25. Binding characteristics of estrogen receptor (ER) in Atlantic croaker (Micropogonias undulatus) testis: different affinity for estrogens and xenobiotics from that of hepatic ER.
Loomis AK; Thomas P
Biol Reprod; 1999 Jul; 61(1):51-60. PubMed ID: 10377031
[TBL] [Abstract][Full Text] [Related]
26. Tamoxifen inhibition of prolactin action in the mouse mammary gland.
Biswas R; Vonderhaar BK
Endocrinology; 1991 Jan; 128(1):532-8. PubMed ID: 1846110
[TBL] [Abstract][Full Text] [Related]
27. Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene.
Watts CK; Murphy LC; Sutherland RL
J Biol Chem; 1984 Apr; 259(7):4223-9. PubMed ID: 6707003
[TBL] [Abstract][Full Text] [Related]
28. High-affinity binding sites for oxygenated sterols in rat liver microsomes: possible identity with antiestrogen binding sites.
Hwang PL
Biochim Biophys Acta; 1990 Feb; 1033(2):154-61. PubMed ID: 2306459
[TBL] [Abstract][Full Text] [Related]
29. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
Coezy E; Borgna JL; Rochefort H
Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
[TBL] [Abstract][Full Text] [Related]
30. Modifications in the aminoether side chain of clomiphene influence affinity for a specific antiestrogen binding site in MCF 7 cells cytosol.
Murphy LC; Sutherland RL
Biochem Biophys Res Commun; 1981 Jun; 100(3):1353-60. PubMed ID: 7271803
[No Abstract] [Full Text] [Related]
31. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of electrophoretic mobilities of [3H]-estradiol and monohydroxytamoxifen binding components in the cytosols of human breast carcinomas and sera of healthy adult females.
Raam S; D'Agincourt PG; Jordan VC
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1457-65. PubMed ID: 6685632
[TBL] [Abstract][Full Text] [Related]
33. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
34. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity.
Gyling M; Leclercq G
J Steroid Biochem; 1988 Jan; 29(1):1-8. PubMed ID: 3347042
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of the microsomal tamoxifen binding site.
Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
[TBL] [Abstract][Full Text] [Related]
36. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
Murphy PR; Butts C; Lazier CB
Endocrinology; 1984 Jul; 115(1):420-6. PubMed ID: 6734522
[TBL] [Abstract][Full Text] [Related]
37. Antiestrogen binding sites in rat liver nuclei.
Kon OL
Biochim Biophys Acta; 1985 Dec; 843(3):245-53. PubMed ID: 4063396
[TBL] [Abstract][Full Text] [Related]
38. Elevated concentrations of antiestrogen binding sites in membrane fractions of human ovarian tumors.
Batra S; Iosif CS
Gynecol Oncol; 1996 Feb; 60(2):228-32. PubMed ID: 8631543
[TBL] [Abstract][Full Text] [Related]
39. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
Keene JL; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
[TBL] [Abstract][Full Text] [Related]
40. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
